CombiPatch vs Climara Pro: What Actually Differs (2026)

Best for you if / not for you if

CombiPatch vs Climara Pro at a glance

Every cell below comes from each product's own FDA label. Read the note underneath. It matters more than the table.

Before you use this table, understand its limits. Every number comes from each drug's own prescribing information. These two patches have never been tested against each other. We searched the published literature and found no randomized trial comparing CombiPatch and Climara Pro head to head.

CombiPatch's own label makes the point for us. Its adverse-reactions section opens by stating that because clinical trials are run under widely varying conditions, the rates seen in one drug's trials cannot be directly compared to the rates seen in another drug's trials.

So when one column shows a higher number, it does not mean that drug causes more of that thing. Further down, we'll show you exactly how badly the comparison breaks — with a number from the FDA's own tables that nobody has put side by side before.

The right patch is not the same for every woman

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to match your situation to the right provider before your first consult.

What we actually verified

We opened both current FDA prescribing labels on DailyMed and wrote down their revision dates. We checked both products against the FDA's official list of menopausal hormone therapies with updated prescribing information. We checked both against the FDA Drug Shortage Database and the American Society of Health-System Pharmacists (ASHP) shortage bulletin. We pulled cash prices and manufacturer program terms from GoodRx, SingleCare, Drugs.com, and each drugmaker's own savings page.

We did not test these products. No clinician reviewed this page. It is editorial research, and every number below can be traced to a dated source we've named.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

What's the actual difference between CombiPatch and Climara Pro?

CombiPatch and Climara Pro are both prescription skin patches that deliver estrogen and a progestin at the same time. CombiPatch pairs estradiol with norethindrone acetate and is replaced every three to four days. Climara Pro pairs estradiol with levonorgestrel and is replaced once every seven days. Both are FDA-approved brand-name products, and both are made for women who still have a uterus.

Two words in there are doing a lot of work.

Estradiol is the main estrogen your ovaries used to make. Both patches deliver the exact same estrogen. That part is identical.

A progestin is a lab-made hormone that acts like progesterone. It is not progesterone. It's in there for one reason. When you take estrogen and you still have a uterus, the lining of the uterus can thicken. That thickening — endometrial hyperplasia — may be a precursor to endometrial cancer. Adding a progestin has been shown to reduce that risk. Those are the label's own words, and note the verb: reduce, not eliminate.

This is where a lot of what's written about these drugs goes badly wrong.

Both of these patches already contain a progestin.

We say that plainly because a widely-read comparison page states that Climara Pro “does not contain any progesterone component,” and then tells women with a uterus to take a progestin alongside it. That page contradicts itself three sentences earlier, where it correctly says Climara Pro contains levonorgestrel.

So, to be clear: Climara Pro contains levonorgestrel. CombiPatch contains norethindrone acetate. Both are progestins. Both are there to protect the uterine lining. Do not add a second progestogen unless your clinician specifically tells you to.

Neither of these is a compounded hormone. Both went through the full FDA approval process and are manufactured to a fixed, tested dose. Compounded hormones are mixed by a pharmacy and are not FDA-approved for safety, effectiveness, or manufacturing consistency. The two are different regulatory categories, and we never treat them as equivalent.

Which is better, CombiPatch or Climara Pro?

Neither wins outright. The better patch depends on what you're treating, how your skin handles adhesive, and what your insurance will pay for. CombiPatch is the stronger option if you have vaginal symptoms, need a flexible progestin dose, or want a smaller patch. Climara Pro is the stronger option if you want one patch change a week or your clinician is also thinking about your bones.

Find yourself in this table. This is the whole decision.

Most women who land here fit one of the first four rows. That's not an accident. The FDA-approved uses are what actually decide this— and almost nothing written about these two drugs leads with them.

Three questions get you most of the way there, and you can answer them right now, in your head. Do you have a uterus? Is your main problem hot flashes, vaginal symptoms, bones — or more than one? Have patches stayed on you before?

If you know those three answers, you already know more walking into this appointment than most women do walking out.

What is each patch actually FDA-approved to treat?

Both patches are FDA-approved for moderate to severe hot flashes and night sweats caused by menopause. From there they split. CombiPatch is additionally approved for moderate to severe vulvar and vaginal atrophy, and for low estrogen caused by hypogonadism, castration, or primary ovarian failure. Climara Pro is additionally approved to prevent postmenopausal osteoporosis. Neither is approved for the other's extra uses.

The word “approved” is doing real work there. It doesn't mean the other drug won't help. It means only one of them was studied for that purpose and cleared by the FDA for it — and that's the language your clinician and your insurance company both speak.

If your main problem is vaginal dryness or painful sex

CombiPatch is approved for it. But read the fine print on its own label, because it's more honest than most articles about it: when prescribing solely for the treatment of vulvar and vaginal atrophy, topical vaginal products should be considered.

That's the drugmaker telling you not to use a whole-body hormone patch for a local problem. Take it seriously. A vaginal estrogen cream, tablet, or ring delivers a much smaller amount of hormone and largely stays where you put it. Start there. → Vaginal estrogen options

If you have hot flashes and vaginal symptoms, that changes things. Now the patch is doing two jobs, and CombiPatch is the one labeled for both.

If your clinician is worried about your bones

Climara Pro is approved to prevent postmenopausal osteoporosis. Its label reports one-year bone mineral density results supporting that use: lumbar-spine density rose 1.7% while it fell 2.9% on placebo, and total-hip density rose 1.3% while it fell 0.9% on placebo.

Two things to hold onto. First, that is not a head-to-head comparison with CombiPatch — CombiPatch has no osteoporosis indication and no bone data on its label at all. Second, Climara Pro's label pushes back on itself: if bone protection is the onlyreason you'd take it, the label says non-estrogen medications should be carefully considered first.

So Climara Pro is not “the bone patch.” It's the patch that covers bone protection whileit's already treating your hot flashes. That's a different claim, and it's the accurate one.

If your ovaries stopped early

This is the quietest, most underserved group on this page. If you went through menopause before 40, had your ovaries removed, or have primary ovarian failure, CombiPatch is the only one of these two that's FDA-approved for your situation.Climara Pro's label doesn't cover it.

Women in this group are often handed whatever the formulary prefers. If that's you, this is the single most useful sentence we can give you. Write it down and bring it.

Norethindrone acetate vs levonorgestrel: does the progestin matter?

Both progestins do the main job. In each drug's own one-year study, the combination patch sharply reduced the thickening of the uterine lining that estrogen alone can cause. The two hormones behave differently in the body: norethindrone clears with a half-life of about 6 to 8 hours, while levonorgestrel's is roughly 28 hours. No study has ever compared them head to head in these two patches.

Here's what each label recorded on endometrial hyperplasia — the thickening the progestin exists to reduce. In every one of these trials, the comparison arm was an estradiol-only patch.

Look at the women taking estrogen without a progestin. Thirty-eight percent. Twenty percent. Seventeen percent. That is why the progestin is in the patch, and it is why you don't get to skip it if you have a uterus.

Now the part nobody assembles for you:

Based on those half-lives alone, levonorgestrel would be expected to clear more slowly than norethindrone after a patch comes off. Whether that matters clinically has not been studied.

And a bigger caution: these numbers come from separate trials using separate methods. A higher blood level of one progestin does not mean a stronger effect, more side effects, or a better outcome. Different progestins are active at very different concentrations. Comparing 840 to 166 is comparing two different molecules on two different scales.

What isworth acting on: if you've had a rough time with one progestin before — norethindrone in a birth control pill years ago, say — tell your clinician. It's one of the few pieces of information that can genuinely steer this decision.

Once a week or twice a week — and which patch actually stays on?

Climara Pro is replaced once every seven days. CombiPatch is replaced every three to four days. CombiPatch's label reports that across six clinical trials in 1,287 women, the patch stayed fully adhered nearly 90% of the time over its 3-to-4-day wear period, with under 2% needing reapplication. Climara Pro's label reports acceptable weekly adhesion in a separate study, and warns that swimming, bathing, and sauna use were never studied and may reduce adhesion or hormone delivery.

Once a week sounds obviously better. Four patches instead of eight. Fewer sticky squares, fewer phone reminders.

It's only better if the patch stays on for all seven days.

What CombiPatch's label reports.Across six trials lasting three months to a year, in 1,287 women, the patch fully adhered about 90% of the time over its wear period. Fewer than 2% of patches needed reapplication or replacement. Two women — 0.2% — quit because the patch wouldn't stick. And the label states directly that bathing, swimming, and showering will not affect it.

What Climara Pro's label reports. In a separate adhesion study in healthy women aged 45 to 75, weekly adhesion was rated clinically acceptable. But the label says plainly that swimming, bathing, and sauna use were not studied, and may decrease adhesion or how much hormone gets through.

And what Climara Pro's label also reports — the number that should shape your expectations:

• In its trials, 40.6% of women had a skin reaction where the patch sat, compared with 33.8% on an estradiol-only patch.
• In the 12-week study, 2.1% of women stopped because of it.
• In the one-year study, 8.5% stopped because of it.

Roughly one in twelve women quit Climara Pro over the patch site itself.

We're not going to tell you CombiPatch sticks better. Those are different trials with different definitions and different scoring. What we will tell you is this: “once a week is easier” is only true for the woman it stays on for seven days.A weekly patch that peels on day five is worse than a twice-weekly patch that never fails, because now you're improvising.

If patches have historically slid off you — after workouts, in humid weather, in a long bath — that's real evidence about your skin, and it belongs in the conversation.

If your patch comes off

Both labels answer this.

• CombiPatch: put the same patch back on, or apply a new one to a different spot on your lower abdomen. Then stay on your original schedule. Don't shift your change days.
• Climara Pro: press firmly on the edges if it's lifting. If it comes off entirely, reapply it or put on a new one for whatever's left of the seven-day stretch. Your change day stays the same.

Don't tape it down, don't add adhesive, don't cover it with anything unless your pharmacist or clinician tells you to. And don't cut either patch. Nothing on either label supports it.

The storage detail nobody mentions

Here's something you won't find on another comparison page, and it will save you a phone call.

CombiPatch's prescribing information tells the pharmacy to keep it refrigerated at 36–46°F before dispensing. Once it's dispensed to you, the label says it can be kept at room temperature — and the pharmacist is instructed to write an expiration date on your box that does not go beyond six months from the date of sale.

So CombiPatch arrives with a six-month clock on it. Climara Pro is stored at room temperature, and we found no comparable six-month limit in its labeling.

That's worth knowing before you ask for a 90-day fill, and worth knowing if you were thinking about stocking up during a supply crunch. Some consumer drug websites still tell patients to keep CombiPatch in the fridge at home. Follow the box you were handed, and ask your pharmacist— they're the one who wrote the date on it.

Did the FDA remove the boxed warning from CombiPatch or Climara Pro?

No. On February 12, 2026, the FDA approved labeling changes to six menopausal hormone therapy products, removing the language about cardiovascular disease, breast cancer, and probable dementia from the boxed warning. Neither CombiPatch nor Climara Pro was among those six. As of July 2026, both still carry the full boxed warning on their current FDA labels.

This is the section we built this page for.

In November 2025, HHS and the FDA announced they would begin removing what most people call the “black box warning” from menopausal hormone therapy. In February 2026, the FDA followed through on a first group of products. It was covered everywhere. Millions of women read the headline.

Then they picked up their patch box. The warning was still there.

Here is the actual list. The FDA publishes it. These are the six products whose prescribing information was updated on February 12, 2026:

Bijuva is the only combination product on that list. CombiPatch is not on it. Climara Pro is not on it.

We confirmed it against both labels directly:

• CombiPatch's current label on DailyMed was last updated February 21, 2024 — two years before the FDA's action. Its boxed warning is still headed Cardiovascular Disorders, Breast Cancer, Endometrial Cancer, and Probable Dementia.
• Climara Pro's current label was revised in December 2023. The posting was refreshed in March 2026, but the boxed warning is unchanged and still names cardiovascular disorders, probable dementia, breast cancer, and endometrial cancer.
• Bayer's own site for prescribers still directs them to the full prescribing information, including the boxed warning.

So what does the warning on your box actually mean?

It means the label on your patch has not yet been reviewed and revised. That's it. The FDA explicitly called February 12 the first batch. More products are expected. Whether these two are included, and when, nobody has said.

It also means the warning text you're reading was written after a 2002 study in women whose average age was 63 — more than a decade past the average age of menopause — using an oral hormone formulation that isn't in common use today. The label says so itself: those risks were assumed to apply to other doses and other dosage forms of estrogen and progestin, in the absence of comparable data.

Worth knowing: the endometrial cancer warning was not removed, even for the six products that were updated. The FDA kept it for estrogen-alone products.

We're not going to tell you the warning doesn't matter. We're telling you exactly what it is, when it was written, which products the FDA has revisited, and which ones it hasn't. That's a different thing than reassurance, and it's more useful.

The Menopause Society, the leading professional body in this field, has said that for younger, healthy women starting hormone therapy near the menopause transition, the risks are low — and that they rise for women who are older and further from menopause when they start. That's the conversation to have with your clinician. The box on your carton is not that conversation. → Benefits and risks of HRT

How much do CombiPatch and Climara Pro cost in 2026?

Both are brand-name-only products with no generic, and cash prices are close. With a discount card, a one-month supply of either typically runs somewhere between roughly $240 and $320, depending on the pharmacy, your ZIP code, and which card you use. What separates them is not the sticker price. It's the assistance program sitting behind each one, and whether your insurance is private, government, or nonexistent.

The sticker price

Both are a month's supply. CombiPatch comes as eight patches because you change it twice a week. Climara Pro comes as four because you change it once. Don't read “8 versus 4” as “twice as much medicine.”

Prices move. Everything here was checked on July 9, 2026. GoodRx listed its Climara Pro coupon prices as last updated June 25, 2026. Check your own ZIP code before you decide anything.

What you'll really pay

This is the table that matters, and this is where the two drugs stop being twins.

Read that last row again.

If you're uninsured and your income is low, Bayer has a documented program that can supply Climara Pro at no cost. We searched for an equivalent program for CombiPatch and could not identify one. Noven runs a copay savings card, and prescribers can request samples, but that is not the same as free medication.

For a woman paying roughly $250 a month out of pocket, that gap is around $3,000 a year. It is the single largest difference between these two drugs, and we have not seen another page mention it.

Be precise about what we're saying. We could not find a patient assistance program for CombiPatch. That is not proof none exists. Noven's copay support line is 1-833-483-2178.Call before you rule anything out. And confirm Bayer's current eligibility rules and how the medication is delivered before you count on it.

Now notice what both cards have in common. They are void for Medicare, Medicaid, TRICARE, and the VA. The women most likely to need help paying are the ones locked out of the help.That isn't a loophole. It's federal law, and it applies to nearly every brand-name drug in America.

Which brings us to the part of this page that might cost us your click.

The honest part: neither of these is the affordable choice

Neither CombiPatch nor Climara Pro is the cheapest FDA-approved way to take estrogen with a progestin. Both are brand-name-only, both sit on non-preferred insurance tiers, and both manufacturer savings cards exclude government insurance. A generic estradiol patch paired with a separate FDA-approved progestogen delivers the same two hormone classes for a fraction of the cost.

Let's do the math out loud, because you deserve it.

A generic estradiol patch runs roughly $25 to $60 for a box of four with a discount card. Add a separate generic progestogen. You are very likely under $100 a month.

CombiPatch or Climara Pro will cost you $240 to $320 without help.

So why does anyone pay four times as much?

Because a combination patch is one patch. Not a patch plus a pill you have to remember every night. Not two prescriptions, two refills, two copays, two chances for the pharmacy to be out of stock. Sticking with one thing is not the same as sticking with two, and hormone therapy only works when you actually use it.

Because of the approvals.Climara Pro is the only option in this entire conversation that is FDA-approved to prevent postmenopausal osteoporosis. CombiPatch is the only one FDA-approved for vulvar and vaginal atrophy and for early ovarian failure. A generic estradiol patch plus a separate progestogen is a legitimate regimen — each piece is FDA-approved on its own — but it is not the same fixed-dose combination product, and it does not carry the same approved uses. If you need your insurer to cover treatment for those specific things, that distinction has teeth.

And because of what you're actually buying.You are not paying a premium for better hormones. The estradiol is identical. You're paying for a specific approved indication, and for one point of failure instead of two.

If that trade isn't worth it to you — and for a lot of women it genuinely isn't — take the generic route. It's real, it's FDA-approved, and your clinician can write it today. Nobody should make you feel cheap for asking. Wanting treatment you can actually afford to keep taking is not settling. It's the whole point.

Now — with that on the table — everything after this you can trust a little more.

Is there a generic for CombiPatch or Climara Pro?

No. As of mid-2026, the FDA has not approved a generic version of either product. Drugs.com's generic-availability records, GoodRx, and SingleCare all report no generic equivalent for either drug. Generic estradiol-only patches do exist and cost far less, but they contain no progestin.

You will find pages claiming a generic CombiPatch exists and even quoting a monthly price for it. There is no FDA-approved generic to price.

The confusion is understandable, because “generic” means two different things.

An ANDA generic is what most people mean: a different company gets FDA approval to make its own version, competition arrives, and the price drops. Neither of these drugs has one. An authorized genericis something else — the brand-name product, made in the same plant by the same company, sold in a plain box under the chemical name. Same drug, different clothes, sometimes a lower price.

Ask your pharmacist whether either exists for the patch you've been prescribed. It's a thirty-second question, and it occasionally saves real money.

What “no generic” actually costs you

It's not only the sticker price. No generic means:

• Your plan will almost always park it on a non-preferred brand tier.
• Prior authorization becomes likely, not optional.
• Some plans will require you to fail an oral hormone first. That's called step therapy.
• Medicare Part D coverage gets unreliable.

Generic estradiol patches usually sit on the lowest copay tier. That's not a small gap. That's the gap.

And to be perfectly clear: a generic estradiol patch is not a substitute for either of these. It is estrogen alone. If you have a uterus and you take estrogen alone, you need a progestogen from somewhere. Never make that swap on your own.

Is CombiPatch or Climara Pro in shortage right now?

Neither product appears on the FDA's Drug Shortage Database. The widely reported 2026 hormone patch shortage is documented for estradiol-only patches, not for these two combination patches. The FDA and the American Society of Health-System Pharmacists currently disagree about whether an estradiol patch shortage exists at all, because they use different methods to decide.

If you've called four pharmacies this month, you're not imagining it. But the details matter.

What ASHP lists. Its estradiol transdermal system bulletin — which ASHP revises as manufacturers report in — lists affected estradiol-only patch products from Sandoz, Amneal (Dotti and Lyllana), Noven and its distributor Grove, and Zydus. It lists Viatris estradiol patches and Bayer's Climara among available products, not affected ones.

Read that again. Climara is a single-hormone estradiol patch. Climara Pro is a different product. Neither Climara Pro nor CombiPatch appears on the affected list.

What the FDA lists. Nothing. An FDA spokesperson has said estradiol patches are not in shortage, and that all six manufacturers report running at full capacity while trying to keep up with demand.

Two databases. Two answers. ASHP builds its list from what pharmacists and providers report at the counter. The FDA builds its list from what manufacturers report about their production lines. A factory can be running flat out and your pharmacy shelf can still be empty. Both statements are true at once, and nobody is lying to you.

Why demand exploded.After the FDA moved to strip the boxed warning, prescriptions surged. CNBC, citing health-data firm HealthVerity, reported that estrogen patch prescriptions rose 162% over two years. Patches are also genuinely hard to manufacture — makers describe them as complex, and generic producers often run a single batch a year on a shared line. You cannot simply turn the dial up in March.

If your pharmacy can't fill it.Ask them to check both strengths. Ask whether another branch in the chain has it. Ask your prescriber whether a 90-day fill is possible, which can route you to a mail-order pharmacy with deeper stock — though remember CombiPatch's six-month clock. And if you're told to wait weeks, ask whether a different formulation makes sense for now.

Don't just stop. Stopping hormone therapy abruptly brings the symptoms back, and that's a decision to make with a clinician, not a pharmacy tech.

What are the side effects of CombiPatch and Climara Pro?

Both labels report skin reactions at the patch site, vaginal bleeding, and breast tenderness as common. In CombiPatch's 12-week studies, 25% to 31% of women reported breast pain, versus 7% on placebo, and 20% to 21% reported menstrual cramps, versus 5% on placebo. In Climara Pro's trials, 40.6% reported a skin reaction at the patch site and 18.9% reported breast pain. These figures come from separate studies and cannot be compared directly against one another.

CombiPatch, 12 weeks, versus placebo

Reactions reported by at least 5% of women. Groups of 113, 112, and 107.

Notice headache. It showed up just as often on placebo. That's what a control group is for — and it's why headache belongs at the bottom of your worry list and breast tenderness belongs near the top.

Now the thing that proves you cannot compare these two drugs

Both patches also ran one-year trials. In both, the comparison group wore an estradiol-only patch— the same class of drug, doing the same job in the study.

Put those two comparison arms side by side. Same kind of drug. Same job in the study.

Breast pain in CombiPatch's comparison arm: 40%. Breast pain in Climara Pro's comparison arm: 9.8%.

A fourfold gap — in the controlgroups. Those two trials were not asking women the same questions, in the same way, with the same prompting. That single pair of numbers is the proof, sitting in the FDA's own tables, that reading across these two labels tells you nothing about which patch will treat you better or worse.

CombiPatch's label says as much in its opening line on adverse reactions: rates from one drug's trials cannot be directly compared to rates from another drug's trials.

So anyone who tells you “CombiPatch causes more breast pain” or “Climara Pro irritates skin more” is reading two different rulers and calling it a measurement.

About the bleeding

This is the side effect that frightens women most and gets explained least.

When you start a continuous combination patch, breakthrough bleeding and spotting are common early on. It usually settles. On CombiPatch, by cycles 10 through 12, 53% of women on the lower dose and 39% on the higher dose had stopped bleeding entirely. Women who did bleed generally described it as light, lasting four to six days.

Which also means roughly half were still having some bleeding at the one-year mark on the lower dose. That's not a complication. It's the expected pattern, and it's on the label.

But: any bleeding after menopause deserves a call to your clinician.Not a panic. A call. There's a difference between expected breakthrough bleeding on a new hormone patch and bleeding that needs to be looked at, and only a clinician can draw that line.

Who should not use CombiPatch or Climara Pro?

Both patches share the same contraindications: undiagnosed abnormal genital bleeding, known or suspected breast cancer, estrogen-dependent cancers, active or prior blood clots, active or prior stroke or heart attack, liver impairment or disease, known clotting disorders such as protein C or protein S deficiency, known allergy to the product, and known or suspected pregnancy. Both are intended only for women who still have a uterus.

We're going to be blunt, because comparison tables can make a serious medication feel like a shopping decision.

Not because these are dangerous drugs. Because these are exactly the situations where a comparison article is the wrong tool and a person who can examine you and read your records is the right one.

And if you've had a hysterectomy:neither patch is for you. The progestin is there to protect a uterus you no longer have. CombiPatch's patient labeling says so directly. Estrogen alone is the usual conversation after a hysterectomy — but that's your clinician's call, not ours.

This is the part where we tell you to leave. We'd rather lose you here than have you make a decision this page wasn't built for.

Can you switch between CombiPatch and Climara Pro?

Yes, but it's a clinical decision, not a swap. Both labels say a woman already on continuous estrogen or estrogen-plus-progestogen therapy should finish her current cycle before starting the new patch, and that the first day of withdrawal bleeding is a reasonable time to begin. A woman not currently on hormone therapy can start at any time.

A few practical things worth knowing before that appointment.

The regimens aren't identical. CombiPatch can be used two ways. Continuous combined means you wear it all 28 days. Continuous sequential means you wear a separate estradiol-only patch for the first 14 days, then switch to CombiPatch for the last 14. That second option is a two-patch regimen, and it's worth knowing that before you agree to it. Climara Pro has no sequential option.

Your patch-change day will change. Going from twice weekly to once weekly, or the reverse, means a new rhythm. Put it in your phone before you leave the pharmacy.

The progestin changes. If one gave you a hard time, say so.

The clock changes. CombiPatch carries a six-month expiration from the date your pharmacy dispenses it. Climara Pro doesn't.

Four questions to bring with you

1. Which of my symptoms are we actually treating — hot flashes, vaginal symptoms, bones, or more than one?
2. Do I have a reason to prefer one progestin over the other?
3. Will my insurance cover this patch, and will it need prior authorization?
4. If I can't afford it, is a generic estradiol patch plus a separate progestogen a reasonable option for me?

That fourth question saves women the most money, and it's the one they almost never ask.

What women actually run into

The reports below come from public patient forums. They describe cost and logistics — not safety, not effectiveness. They are individual experiences and may not resemble yours.

On Mayo Clinic Connect's public discussion of CombiPatch copays, the friction women describe has almost nothing to do with hormones. One woman reports a $135 copay in Maine. Another describes being charged around $230 even while using a GoodRx coupon, and being told to try a different pharmacy. Others in the thread point out that the lack of a generic is what drives the high tier — and several describe moving to a generic estradiol patch with progesterone taken separately.

Three things surface over and over: the price is not what you expected, it varies wildly by pharmacy, and the cheapest FDA-approved answer is often the one nobody offered you.

That's the whole reason this page exists.

How to get a prescription — and pay less than the sticker price

Both patches are prescription-only, and both frequently require prior authorization because neither has a generic. The path that works depends entirely on your insurance. Women with private insurance should get the prescription and then apply the manufacturer copay card. Women without insurance should ask their prescriber about Bayer's patient assistance program for Climara Pro.

Here's the sequence, in order.

If you have private insurance.Get the prescription. Before you fill it, check whether the drug is on your plan's formulary and whether it needs prior authorization. If it does, your clinician submits paperwork explaining why a combination patch is right for you — commonly, that you can't tolerate oral hormones, or that you have clotting risk factors that favor a patch. Then apply the manufacturer card. Both can bring your copay to as little as $25.

If you're paying cash.Get the prescription first. Then compare GoodRx and SingleCare at three pharmacies near you before filling — the spread between pharmacies in the same city can exceed $50. Then ask whether the manufacturer card can be applied on top. Noven's CombiPatch offer covers cash-paying patients, not just insured ones.

If you're uninsured and low income.Ask your prescriber about the Bayer Patient Assistance Program for Climara Pro. It's income-based, and it can provide the medication at no cost to patients who qualify. For the women it applies to, this is the single highest-value action on this entire page.

If you're on Medicare or Medicaid. Neither savings card works for you. Check your plan's formulary directly. And have the generic conversation — seriously. → HRT insurance coverage

Where the clinician comes from

You need a prescriber. That can be your gynecologist, a primary care doctor, or a telehealth clinician licensed in your state.

If you don't have someone, two providers we've reviewed serve two different situations.

If you have insurance and want it used. Midi Health works with insurance and prescribes FDA-approved menopause medications. That matters here, because a brand-name combination patch on a non-preferred tier is exactly the kind of drug you want billed through your plan and, if necessary, backed by a prior authorization your clinician actually files.

See whether Midi Health takes your insurance → (affiliate link — see our disclosure)

If you're paying cash and just need the prescription.Sesame Care lets you book a cash-pay visit with a licensed clinician at a published price, with no insurance involved. If your goal is to walk into the pharmacy holding a valid prescription and a manufacturer savings card, that's the shortest path there.

Check cash-pay visit availability on Sesame Care → (affiliate link — see our disclosure)

Before you book, check these four things

Take sixty seconds. It's the same list we'd use.

1. Are they licensed in your state? Telehealth prescribing is state-by-state.
2. Do they prescribe FDA-approved medications? Some online menopause providers work primarily with compounded hormones, which are mixed by a pharmacy and are not FDA-approved for safety, effectiveness, or manufacturing consistency. If you came here for CombiPatch or Climara Pro, that matters. → FDA-approved vs compounded HRT
3. Will they file a prior authorization? For a brand-name combination patch, this is often the difference between $25 and $300.
4. What happens if the drug isn't right for you? A good clinician will say so. That's the point of the visit.

That's also why we don't feature compounded-first providers on this page. It wouldn't be the right answer to the question you actually asked.

If you've read this far, you are not looking for permission to want relief. You're looking for the confidence to ask for the right thing. You have it now. Book the appointment.

How we verified this page

We used The HRT Index Verification Standard — the documented process by which we review providers and products: read every published price, separate FDA-approved from compounded, verify state availability and insurance, and re-check on a fixed schedule.

What we checked, and where:

• Ingredients, strengths, patch sizes, wear schedules, application sites, storage, indications, contraindications, adhesion data, hormone blood levels, endometrial hyperplasia rates, and every adverse-reaction row — from the current FDA prescribing information for each product on DailyMed, the National Library of Medicine's official label database. CombiPatch's label was last updated February 21, 2024. Climara Pro's was revised December 2023, posting updated March 26, 2026.
• Boxed warning status — against the FDA's published list of menopausal hormone therapies with updated prescribing information, current as of February 12, 2026, and the FDA's press announcement of the same date.
• Shortage status — against the FDA Drug Shortage Database and ASHP's estradiol transdermal system bulletin.
• Prices — GoodRx and SingleCare product pages, checked July 9, 2026. GoodRx listed its Climara Pro coupon prices as last updated June 25, 2026.
• Savings and assistance programs — Noven's CombiPatch savings offer terms, Bayer's Climara Pro savings page, Drugs.com's price guides for both products, and public listings of the Bayer Patient Assistance Program.
• Head-to-head evidence — we searched the published literature for a randomized trial comparing these two products directly. We found none.
• Cost and access friction — public patient forums, used only to understand what women run into, never as evidence about safety or effectiveness.

When we check again. Prices and shortage status: monthly. Boxed warning status and label revision dates: monthly, because the FDA has said more products are coming. Manufacturer programs and generic approval status: quarterly.

No clinician reviewed this page, and we won't pretend otherwise. It's editorial research, sourced and dated. We'd rather tell you that than invent a credential.